NCT02727803 2025-11-06Personalized NK Cell Therapy in CBTM.D. Anderson Cancer CenterPhase 2 Recruiting100 enrolled
NCT03401853 2025-07-22Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell LymphomaUniversity of WashingtonPhase 2 Terminated18 enrolled 14 charts
NCT03096782 2023-10-11Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or LymphomaM.D. Anderson Cancer CenterPhase 2 Completed6 enrolled 10 charts
NCT04155840 2022-04-11Bendamustine and Rituximab in Combination With Copanlisib for the Treatment of Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaUniversity of WashingtonPhase 2 Terminated1 enrolled 6 charts